Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshoka India Equity Investment Trust Plc Regulatory News (AIE)

Share Price Information for Ashoka India Equity Investment Trust Plc (AIE)

Share Price is delayed by 15 minutes
Get Live Data
235.50    0.00 (0.00%)
Bid:
233.50
Ask:
236.50
Spread: 3.00 (1.285%)
Market Cap: £398.74m
AIE Live PriceLast checked at - London Stock Exchange

Intraday Ashoka India Equity Investment Trust Plc Share Chart

Performance Fee and Total Voting Rights

22 Oct 2024 14:22

RNS Number : 1721J
Ashoka India Equity Investment Tst
22 October 2024
 

22 October 2024

 

LEI: 213800KX5ZS1NGAR2J89

 

 

Ashoka India Equity Investment Trust plc

(the "Company")

 

Issue of Ordinary Shares

 

Ashoka India Equity Trust plc (the "Company") announces that it will issue 807,246 new ordinary shares of one penny each (the "New Ordinary Shares") to Acorn Asset Management Ltd (the "Investment Manager"), in relation to the performance fee which has become due in respect of the three-year period from 1 July 2021 to 30 June 2024, being the second performance fee payable by the Company.

 

As detailed in the Company's prospectuses published in June 2018 in connection with its IPO and in April 2024 in connection with the Company's share issuance programme and the Performance Fee Issue (the "2024 Prospectus"), the Investment Manager does not receive a fixed management fee from the Company. Instead, the Investment Manager is entitled to receive a performance fee subject to meeting the relevant performance criteria (the "Performance Fee"). The Performance Fee, which is measured over consecutive, discrete performance periods of three years, is designed to reward investment outperformance by the Investment Manager, through delivering excess returns versus the benchmark index to the Company's shareholders over the medium-term.

 

As set out in the Company's audited annual accounts for the year to 30 June 2024, the Investment Manager has delivered outperformance in the three-year period since 30 June 2021 (being the reporting period end applicable to the last performance fee due), delivering returns of 75.8% over the period, 10.8% above the benchmark index, and the resulting Performance Fee for the period is £2,300,571. The Performance Fee is payable to the Investment Manager in the form of new ordinary shares in the Company at the prevailing net asset value at the time of issue. Accordingly, 807,246 New Ordinary Shares will be issued at the prevailing net asset value as at 21 October 2024 of 284.99 pence per Ordinary Share.

 

As detailed in the 2024 Prospectus, the Investment Manager has agreed that at least 50% of any Ordinary Shares acquired by it through the Performance Fee will, save in certain circumstances, be locked in for a period of three years.

 

Further details of the Performance Fee are set out in the 2024 Prospectus, which is available to view on the Company's website https://ashokaindiaequity.com/.

 

Applications have been made for admission of the New Ordinary Shares to the closed-ended investment funds category of the Official List of the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange ("Admission"). It is expected that Admission will occur at 8.00 a.m. on 25 October 2024.

 

Following Admission, the Company's issued ordinary share capital will comprise 162,039,643 ordinary shares of one penny each. The total number of ordinary shares with voting rights in the Company is 162,039,643. This figure (162,039,643) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Apex Listed Companies Services (UK) Limited 020 4582 6470

 

Company Secretary

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEPPGBGUUPCGWP
Date   Source Headline
9th Jun 20261:38 pmRNSNet Asset Value(s)
8th Jun 20261:12 pmRNSNet Asset Value(s)
5th Jun 202612:58 pmRNSNet Asset Value(s)
4th Jun 20261:48 pmRNSNet Asset Value(s)
3rd Jun 202612:48 pmRNSNet Asset Value(s)
2nd Jun 20261:09 pmRNSNet Asset Value(s)
1st Jun 20261:28 pmRNSNet Asset Value(s)
29th May 202612:36 pmRNSNet Asset Value(s)
28th May 202611:43 amRNSNet Asset Value(s)
27th May 202612:55 pmRNSNet Asset Value(s)
26th May 202612:50 pmRNSNet Asset Value(s)
22nd May 20261:07 pmRNSNet Asset Value(s)
21st May 202612:59 pmRNSNet Asset Value(s)
20th May 20261:52 pmRNSNet Asset Value(s)
19th May 20261:19 pmRNSNet Asset Value(s)
18th May 202612:57 pmRNSNet Asset Value(s)
15th May 20261:14 pmRNSNet Asset Value(s)
14th May 20261:32 pmRNSNet Asset Value(s)
13th May 20261:37 pmRNSNet Asset Value(s)
12th May 20261:18 pmRNSNet Asset Value(s)
11th May 20261:38 pmRNSNet Asset Value(s)
8th May 20261:20 pmRNSNet Asset Value(s)
8th May 20267:00 amRNS-RKepler Trust Intelligence: New Research
7th May 202612:58 pmRNSNet Asset Value(s)
6th May 20262:08 pmRNSNet Asset Value(s)
5th May 202612:37 pmRNSNet Asset Value(s)
5th May 202610:05 amRNSHolding(s) in Company
1st May 202612:49 pmRNSNet Asset Value(s)
30th Apr 20261:22 pmRNSNet Asset Value(s)
29th Apr 202612:57 pmRNSNet Asset Value(s)
28th Apr 202612:33 pmRNSNet Asset Value(s)
27th Apr 20265:36 pmRNSDirector/PDMR Shareholding
27th Apr 202612:49 pmRNSNet Asset Value(s)
24th Apr 20262:44 pmRNSHolding(s) in Company
24th Apr 202612:20 pmRNSNet Asset Value(s)
23rd Apr 20261:25 pmRNSNet Asset Value(s)
22nd Apr 20261:28 pmRNSNet Asset Value(s)
21st Apr 20261:51 pmRNSNet Asset Value(s)
20th Apr 20261:55 pmRNSNet Asset Value(s)
17th Apr 20261:35 pmRNSNet Asset Value(s)
16th Apr 20261:36 pmRNSNet Asset Value(s)
15th Apr 20261:33 pmRNSNet Asset Value(s)
14th Apr 202611:40 amRNSNet Asset Value(s)
13th Apr 202612:38 pmRNSNet Asset Value(s)
10th Apr 202612:52 pmRNSNet Asset Value(s)
9th Apr 20261:46 pmRNSNet Asset Value(s)
8th Apr 20261:11 pmRNSNet Asset Value(s)
7th Apr 20261:13 pmRNSNet Asset Value(s)
1st Apr 20262:07 pmRNSNet Asset Value(s)
31st Mar 202611:43 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.